Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

Acu Focus, Inc.

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

Acu Focus, Inc.

Regulatory records
2
Linked recall entries
0
Headquarters
Not reported
Brand website
Not reported
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 2 FDA records to the applicant name Acu Focus, Inc.. 2 entries are PMA supplements. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from Aug 4, 2025 to Jul 14, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code POE appears in 2 of the 2 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

The largest PMA family in this collection is P210005, with 2 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.

Applicant mailing address recorded by FDA: 32 Discovery Suite 200, Irvine, CA, 92618. Recorded on P210005/S010, decision dated Jul 14, 2026.

Changes described in PMA records

P210005/S010: IC-8 Apthera Intraocular Lens (IOL)

FDA’s recorded scope: approval for continuing to conduct the PAS2 study under the currently approved protocol, SAIL-101-PAS2 Protocol Version 3.2, as approved under P210005/S004

Jul 14, 2026 · Normal 180 Day Track No User Fee

P210005/S011: IC-8 Apthera Intraocular Lens (IOL)

FDA’s recorded scope: approval for a change to the address block of your labeling for the IC-8 Apthera IOL to align with other IOLs in the Bausch & Lomb portfolio

Aug 4, 2025 · Special (Immediate Track)

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

Devices & associated records

Product / regulatory recordCompanyPathwayDecision dateSource
Acu Focus, Inc.PMA supplementJul 14, 2026FDA
Acu Focus, Inc.PMA supplementAug 4, 2025FDA
Source information

Source updated Nov 9, 2026. Retrieved Nov 21, 2026.